Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DHR-PB Stock Summary
Top 10 Correlated ETFs
DHR-PB
In the News
DHR-PB Financial details
Company Rating
Strong Buy
Market Cap
916.01B
Income
7.17B
Revenue
31.47B
Book val./share
71.14
Cash/share
8.52
Dividend
50
Dividend %
3.97%
Employees
78K
Optionable
No
Shortable
Yes
Earnings
-
P/E
123.81
Forward P/E
-
PEG
112.04
P/S
28.19
P/B
17.72
P/C
147.92
P/FCF
124.34
Quick Ratio
1.3
Current Ratio
1.89
Debt / Equity
0.68
LT Debt / Equity
0.38
-
-
EPS (TTM)
10.15
EPS next Y
-
EPS next Q
-
EPS this Y
10.39%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
21.79%
Revenue last 5Y
9.61%
Revenue Q/Q
9.21%
EPS Q/Q
42.73%
-
-
-
-
SMA20
-5.01%
SMA50
-7.64%
SMA100
-5.27%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
15%
ROC
0.11%
Gross Margin
60%
Oper. Margin
28%
Profit Margin
23%
Payout
11%
Shs Outstand
726.86M
Shs Float
646.25M
-
-
-
-
Target Price
-
52W Range
1199.99-1621.32
52W High
-22.26%
52W Low
+5.11%
RSI
48.32
Rel Volume
2.82
Avg Volume
7.91K
Volume
22.26K
Perf Week
4.41%
Perf Month
-4.55%
Perf Quarter
-6.48%
Perf Half Y
-14.78%
-
-
-
-
Beta
0.802174
-
-
Volatility
8.14%, 36.93%
Prev Close
0.67%
Price
1260.23999
Change
0.67%
DHR-PB Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 28.26 | 25.44 | 31.65 | 41.84 | 44.7 | |
Net income per share | 3.77 | 4.27 | 5.18 | 9.14 | 10.09 | |
Operating cash flow per share | 5.71 | 5.61 | 8.82 | 11.87 | 12.1 | |
Free cash flow per share | 4.78 | 4.71 | 7.69 | 10.03 | 10.46 | |
Cash per share | 1.12 | 28.28 | 8.57 | 3.67 | 8.52 | |
Book value per share | 40.08 | 43 | 56.49 | 64.16 | 71.14 | |
Tangible book value per share | -13.28 | -3.1 | -24.04 | -26.78 | -14.16 | |
Share holders equity per share | 40.08 | 43 | 56.49 | 64.16 | 71.14 | |
Interest debt per share | 14.06 | 31.24 | 31.89 | 33.39 | 28.25 | |
Market cap | 704.79B | 704.79B | 915.97B | 1223.67B | 955.01B | |
Enterprise value | 713.74B | 706.77B | 932.12B | 1244.36B | 968.69B | |
P/E ratio | 265.87 | 234.29 | 251.23 | 190.22 | 134.45 | |
Price to sales ratio | 35.43 | 39.35 | 41.1 | 41.55 | 30.35 | |
POCF ratio | 175.23 | 178.36 | 147.55 | 146.41 | 112.1 | |
PFCF ratio | 209.37 | 212.54 | 169.09 | 173.23 | 129.63 | |
P/B Ratio | 24.98 | 23.28 | 23.03 | 27.09 | 19.07 | |
PTB ratio | 24.98 | 23.28 | 23.03 | 27.09 | 19.07 | |
EV to sales | 35.88 | 39.46 | 41.83 | 42.25 | 30.78 | |
Enterprise value over EBITDA | 150.01 | 136.46 | 142.42 | 123.33 | 91.22 | |
EV to operating cash flow | 177.46 | 178.86 | 150.15 | 148.88 | 113.71 | |
EV to free cash flow | 212.03 | 213.13 | 172.07 | 176.15 | 131.49 | |
Earnings yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.69 | 1.05 | 0.91 | 0.84 | 0.68 | |
Debt to assets | 0.41 | 0.51 | 0.48 | 0.46 | 0.41 | |
Net debt to EBITDA | 1.88 | 0.38 | 2.47 | 2.05 | 1.29 | |
Current ratio | 1.47 | 5.19 | 1.86 | 1.43 | 1.89 | |
Interest coverage | 21.63 | 30.1 | 15.39 | 31.37 | 41.18 | |
Income quality | 1.52 | 1.31 | 1.7 | 1.3 | 1.18 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.16 | 0.18 | 0.17 | 0.12 | 0.12 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Intangibles to total assets | 0.79 | 0.52 | 0.74 | 0.77 | 0.71 | |
Capex to operating cash flow | -0.16 | -0.16 | -0.13 | -0.15 | -0.14 | |
Capex to revenue | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | |
Capex to depreciation | -0.5 | -0.53 | -0.45 | -0.6 | -0.52 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 58.27 | 64.3 | 81.13 | 114.85 | 127.08 | |
ROIC | 0.06 | 0.12 | 0.06 | 0.08 | 0.11 | |
Return on tangible assets | 0.26 | 0.1 | 0.19 | 0.34 | 0.29 | |
Graham Net | -21.66 | -12.33 | -37.17 | -43.42 | -32.71 | |
Working capital | 2.25B | 20.66B | 6.4B | 3.51B | 7.49B | |
Tangible asset value | -9.35B | -2.18B | -16.93B | -18.85B | -9.97B | |
Net current asset value | -12.51B | -6.2B | -22.58B | -26.36B | -18.39B | |
Invested capital | 0.35 | 0.72 | 0.56 | 0.52 | 0.39 | |
Average receivables | 3.51B | 3.34B | 3.62B | 4.34B | 4.77B | |
Average payables | 1.61B | 1.61B | 1.78B | 2.31B | 2.43B | |
Average inventory | 1.88B | 1.77B | 1.96B | 2.53B | 2.94B | |
Days sales outstanding | 64.03 | 65.04 | 66.25 | 57.39 | 57.04 | |
Days payables outstanding | 71.16 | 69.73 | 76.24 | 81.53 | 66.93 | |
Days of inventory on hand | 79.35 | 74.97 | 85.29 | 87.81 | 90.65 | |
Receivables turnover | 5.7 | 5.61 | 5.51 | 6.36 | 6.4 | |
Payables turnover | 5.13 | 5.23 | 4.79 | 4.48 | 5.45 | |
Inventory turnover | 4.6 | 4.87 | 4.28 | 4.16 | 4.03 | |
ROE | 0.09 | 0.1 | 0.09 | 0.14 | 0.14 | |
Capex per share | -0.93 | -0.9 | -1.12 | -1.84 | -1.64 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2021-12-31 | 2022-04-01 | 2022-07-01 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 11.57 | 10.92 | 11.01 | 10.88 | 11.89 | |
Net income per share | 2.54 | 2.45 | 2.39 | 2.2 | 3.14 | |
Operating cash flow per share | 3.31 | 2.8 | 2.84 | 2.86 | 3.61 | |
Free cash flow per share | 2.72 | 2.44 | 2.42 | 2.46 | 3.14 | |
Cash per share | 3.67 | 5.28 | 5.66 | 7.32 | 8.52 | |
Book value per share | 64.16 | 65.85 | 66.18 | 66.74 | 71.14 | |
Tangible book value per share | -26.78 | -23.36 | -19.29 | -15.95 | -14.16 | |
Share holders equity per share | 64.16 | 65.85 | 66.18 | 66.74 | 71.14 | |
Interest debt per share | 33.14 | 31.01 | 28.57 | 27.4 | 28.04 | |
Market cap | 1223.67B | 1105.89B | 943.11B | 948.63B | 955.01B | |
Enterprise value | 1244.36B | 1123.95B | 959.19B | 962.73B | 968.69B | |
P/E ratio | 171.1 | 160.27 | 140.34 | 152.91 | 108.03 | |
Price to sales ratio | 150.18 | 143.85 | 121.68 | 123.79 | 114.11 | |
POCF ratio | 524.51 | 561.93 | 471.56 | 471.96 | 375.84 | |
PFCF ratio | 639.66 | 643.71 | 553.47 | 547.39 | 431.74 | |
P/B Ratio | 27.09 | 23.86 | 20.24 | 20.19 | 19.07 | |
PTB ratio | 27.09 | 23.86 | 20.24 | 20.19 | 19.07 | |
EV to sales | 152.72 | 146.19 | 123.75 | 125.63 | 115.75 | |
Enterprise value over EBITDA | 456.14 | 413.52 | 358.98 | 386.33 | 336.59 | |
EV to operating cash flow | 533.37 | 571.11 | 479.6 | 478.97 | 381.23 | |
EV to free cash flow | 650.47 | 654.22 | 562.91 | 555.53 | 437.93 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.84 | 0.8 | 0.76 | 0.72 | 0.68 | |
Debt to assets | 0.46 | 0.44 | 0.43 | 0.42 | 0.41 | |
Net debt to EBITDA | 7.58 | 6.64 | 6.02 | 5.66 | 4.75 | |
Current ratio | 1.43 | 1.68 | 1.75 | 1.78 | 1.89 | |
Interest coverage | 38.46 | 40.22 | 43.24 | 47.98 | 35.88 | |
Income quality | 1.3 | 1.14 | 1.19 | 1.28 | 1.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.11 | 0.11 | 0.13 | 0.13 | 0.09 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | |
Intangibles to total assets | 0.77 | 0.75 | 0.74 | 0.72 | 0.71 | |
Capex to operating cash flow | -0.18 | -0.13 | -0.15 | -0.14 | -0.13 | |
Capex to revenue | -0.05 | -0.03 | -0.04 | -0.04 | -0.04 | |
Capex to depreciation | -0.72 | -0.44 | -0.54 | -0.51 | -0.58 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 60.55 | 60.25 | 59.61 | 57.52 | 70.89 | |
ROIC | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | |
Return on tangible assets | 0.09 | 0.08 | 0.08 | 0.07 | 0.09 | |
Graham Net | -43.42 | -40.44 | -37.21 | -34.05 | -32.71 | |
Working capital | 3.51B | 5.12B | 5.67B | 6.25B | 7.49B | |
Tangible asset value | -18.85B | -16.45B | -13.58B | -11.23B | -9.97B | |
Net current asset value | -26.36B | -24.36B | -21.98B | -19.8B | -18.39B | |
Invested capital | 0.52 | 0.47 | 0.43 | 0.41 | 0.39 | |
Average receivables | 4.41B | 4.52B | 4.47B | 4.47B | 4.66B | |
Average payables | 2.35B | 2.46B | 2.39B | 2.31B | 2.24B | |
Average inventory | 2.75B | 2.92B | 3.16B | 3.25B | 3.17B | |
Days sales outstanding | 51.15 | 51.59 | 52.56 | 51.78 | 52.89 | |
Days payables outstanding | 72.14 | 71.11 | 71.85 | 64.04 | 60.24 | |
Days of inventory on hand | 77.7 | 92.69 | 96.74 | 94.59 | 81.6 | |
Receivables turnover | 1.76 | 1.74 | 1.71 | 1.74 | 1.7 | |
Payables turnover | 1.25 | 1.27 | 1.25 | 1.41 | 1.49 | |
Inventory turnover | 1.16 | 0.97 | 0.93 | 0.95 | 1.1 | |
ROE | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | |
Capex per share | -0.6 | -0.36 | -0.42 | -0.39 | -0.47 |
DHR-PB Frequently Asked Questions
What is Danaher Corporation stock symbol ?
Danaher Corporation is a US stock , located in Washington of Dc and trading under the symbol DHR-PB
What is Danaher Corporation stock quote today ?
Danaher Corporation stock price is $1260.23999 today.
Is Danaher Corporation stock public?
Yes, Danaher Corporation is a publicly traded company.